tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
:GSK
US Market

GlaxoSmithKline (GSK) Technical Analysis

Compare
4,937 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is 0.29, suggesting GlaxoSmithKline is a Buy.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 37.01, while GlaxoSmithKline’s (GSK) share price is $34.48, making it a Sell.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 37.07, while GlaxoSmithKline’s (GSK) share price is $34.48, making it a Sell.

GlaxoSmithKline (GSK) Pivot Points

Apr 11, 2025, 04:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
37.17
37.53
38.13
38.49
39.09
39.45
40.05
Fibonacci
37.53
37.89
38.12
38.49
38.85
39.08
39.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Apr 11, 2025, 04:27 AM
Period
Simple
Exponential
MA5
34.72Sell
34.83Sell
MA10
36.56Sell
35.98Sell
MA20
37.89Sell
37.01Sell
MA50
37.42Sell
37.07Sell
MA100
35.52Sell
36.78Sell
MA200
37.20Sell
37.86Sell
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 35.98, while GlaxoSmithKline’s (GSK) share price is $34.48, making it a Sell.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 36.78, while GlaxoSmithKline’s (GSK) share price is $34.48, making it a Sell.
GlaxoSmithKline’s (GSK) stock price is $34.48 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 37.42, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $34.48 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 35.52, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $34.48 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 37.20, creating a Sell signal.

GlaxoSmithKline (GSK) Technical Indicators

Apr 11, 2025, 04:27 AM
Name
Value
Implied Action
RSI (14)
45.13
Neutral
STOCH (9,6)
31.63
Neutral
STOCHRSI (14)
26.43
Neutral
MACD (12,26)
0.29
Buy
ADX (14)
21.42
Neutral
Williams %R
-93.18
Buy
CCI (14)
-129.26
Buy
ATR (14)
0.75
-
Ultimate Oscillator
45.27
Neutral
ROC
-14.37
Sell
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 45.13, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 21.42, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is -129.26, creating a Buy signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is -14.37, creating a Sell signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Strong Sell.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 45.13, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is 0.29, which suggests GSK is a Buy.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 34.72, which suggests GSK is a Sell.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 37.89, which suggests GSK is a Sell.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 37.42, which suggests GSK is a Sell.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 37.20, which suggests GSK is a Sell.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -93.18, which suggests GSK is a Buy.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is -129.26, which suggests GSK is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis